Naltrexone in the treatment of opioid-dependent pregnant women: Common ground

Addiction

Volumn 108, Issue 2, 2013, Pages 255-256

  Jones, Hendrée E ^a,b   Chisolm, Margaret S ^b   Jansson, Lauren M ^b   Terplan, Mishka ^c  

^a RTI INTERNATIONAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; NALTREXONE; NARCOTIC ANTAGONIST;

ANIMAL; BRAIN; DRUG EFFECTS; FEMALE; FETUS DEVELOPMENT; HEROIN DEPENDENCE; HUMAN; MEDICAL ETHICS; METHODOLOGY; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PROCEDURES; DRUG EFFECT; NOTE; OPIATE ADDICTION; PREGNANCY COMPLICATION;

ANIMALS; BRAIN; BUPRENORPHINE; ETHICS, MEDICAL; FEMALE; FETAL DEVELOPMENT; HEROIN DEPENDENCE; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; RESEARCH DESIGN;

EID: 84872584506     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12071     Document Type: Note

References (11)

1. Stitzer M. L. Dual dilemma - should naltrexone be used in the treatment of opioid-dependent pregnant women? Addiction 2013; 108: 249-250.
2. National Alliance on Mental Illness. Scientific Research: Pointing the Way to Hope. 2007 Available from: http://www.nami.org/Content/NavigationMenu/Advocate_Magazine/E-Newsletter/20075/Scientific_Research_Pointing_the_Way_to_Hope.htm (accessed 14 November 2012; archived at http://www.webcitation.org/6CrKXNZSL on 12 December 2012).
3. Waal H. Is sustained release natrexone an option for heroin-dependent pregnant women? Addiction 2013; 108: 252-253.
4. Clark N., Verster A. Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research. Addiction 2013; 108: 253-255.
5. White J. Blocking endogenous opioids during development: do we understand the consequences? Addiction 2013; 108: 251-252.
6. Chervenak F. A., McCullough L. B. Ethics of research and the pregnant patient. Curr Womens Health Rep 2003; 3: 505-509.
7. Chervenak F. A., McCullough L. B. The fetus as a patient: an essential concept for the ethics of perinatal medicine. Am J Perinatol 2003; 20: 399-404.
8. Coverdale J. H., McCullough L. B., Chervenak F. A. The ethics of randomized placebo-controlled trials of antidepressants with pregnant women: a systematic review. Obstet Gynecol 2008; 112: 1361-1368.
9. McCullough L. B., Chervenak F. A. A critical analysis of the concept and discourse of 'unborn child'. Am J Bioeth 2008; 8: 34-39.
10. McCullough L. B., Chervenak F. A. The fetus as a patient and the ethics of human subjects research: response to commentaries on 'An ethically justified framework for clinical investigation to benefit pregnant and fetal patients'. Am J Bioeth 2011; 11: W3-7.
11. McCullough L. B., Chervenak F. A., Coverdale J. H. An ethical framework for conducting research on pregnant, opioid-dependent women. Addiction 2013; 108: 248-249.